Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16ASTRAZENECA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPIVASERTIB

US Patent Number : 11760760

Drug Substance Claim :

Drug Product Claim :

Application Number : 218197

Patent Use Code : U-3762

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-10

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPIVASERTIB

US Patent Number : 11760760

Drug Substance Claim :

Drug Product Claim :

Application Number : 218197

Patent Use Code : U-3762

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-10

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPIVASERTIB

US Patent Number : 10654855

Drug Substance Claim :

Drug Product Claim :

Application Number : 218197

Patent Use Code : U-3762

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-10

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPIVASERTIB

US Patent Number : 10654855

Drug Substance Claim :

Drug Product Claim :

Application Number : 218197

Patent Use Code : U-3762

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-10

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPIVASERTIB

US Patent Number : 10039766

Drug Substance Claim :

Drug Product Claim :

Application Number : 218197

Patent Use Code : U-3762

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-04-16

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPIVASERTIB

US Patent Number : 10039766

Drug Substance Claim :

Drug Product Claim :

Application Number : 218197

Patent Use Code : U-3762

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-04-16

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPIVASERTIB

US Patent Number : 8809336

Drug Substance Claim :

Drug Product Claim :

Application Number : 218197

Patent Use Code : U-3762

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-25

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPIVASERTIB

US Patent Number : 8809336

Drug Substance Claim :

Drug Product Claim :

Application Number : 218197

Patent Use Code : U-3762

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-25

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPIVASERTIB

US Patent Number : 8101623

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 218197

Patent Use Code : U-3762

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-03-10

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPIVASERTIB

US Patent Number : 8101623

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 218197

Patent Use Code : U-3762

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-03-10

blank